investment & stocks ideas
investment & stocks ideas
Favourites   Have ideas?  Sign in / Register

Positive:   Biopharma ↓3.23   Country: Israel ↓3.23   Life Sciences ↓3.15 «See more»   Medicine ↓0.91   Cancer fight ↑1.17   Skin ↑2.68

Disease: Liver stock segment: trending tickers

BIVI BioVie Inc. - Common stock -1.2% -1.2% 0 + Medicine, Disease: Liver

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1580149/000152013826000154/0001520138-26-000154-index.htm
10-Q - BIOVIE INC. (0001580149) (Filer)
+ My List
DCTH Delcath Systems, Inc. - Common Stock -0.34% -0.34% 0 + Cancer fight, Medicine, Disease: Liver

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/872912/000119312526222899/0001193125-26-222899-index.htm
8-K - DELCATH SYSTEMS, INC. (0000872912) (Filer)
+ My List
GALT Galectin Therapeutics Inc. - Common Stock 2.68% 2.68% 0 + Cancer fight, Disease: Liver, Skin, Medicine

Last highlighted: 10-Q Sec report https://www.sec.gov/Archives/edgar/data/1133416/000114036126021495/0001140361-26-021495-index.htm
10-Q - GALECTIN THERAPEUTICS INC (0001133416) (Filer)
+ My List
GLMD Galmed Pharmaceuticals Ltd. - Ordinary Shares -3.23% -3.23% 0 + Disease: Liver, Biopharma, Country: Israel, Medicine

Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1595353/000149315226027640/0001493152-26-027640-index.htm
6-K - Galmed Pharmaceuticals Ltd. (0001595353) (Filer)
+ My List
NDRA ENDRA Life Sciences Inc. - Common Stock -3.15% -3.15% 0 + Life Sciences, Disease: Liver

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1681682/000121390026061701/0001213900-26-061701-index.htm
8-K - ENDRA Life Sciences Inc. (0001681682) (Filer)
+ My List
MODD Modular Medical, Inc. - common stock -2.46% -2.46% 0 + Biotechnology, Medicine, Disease: Liver

Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1074871/000121390026059557/0001213900-26-059557-index.htm
8-K - Modular Medical, Inc. (0001074871) (Filer)
+ My List


We do not provide financial advice. All displayed data is the result of experiments, and a subjective assessment. All decisions that will be made based on this data are made at your own risk. Thank you for understanding.